PROTAC RIPK degrader-6
Product Specifications
UNSPSC Description
Target Antigen
PROTACs; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis;PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-ripk-degrader-6.html
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C(C(OCCOCCOCCOCCOCC(NC1=C(CN(C2C(NC(CC2)=O)=O)C3=O)C3=CC=C1)=O)=C4)=CC(C4=NC=C5)=C5NC6=CC(N=CS7)=C7C=C6)(C(C)(C)C)=O
Molecular Weight
889.00
References & Citations
[1]John David Harlin, et al. Compounds for the modulation of rip2 kinase activity. WO2017046036A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111870/PROTAC-RIPK-degrader-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111870/PROTAC-RIPK-degrader-6-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2089205-64-9
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
